Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Northwest Biotherapeutics's enterprise value was $270.60M on Oct 19, 2026, against $365.90M a year earlier. Over the last 5 years it ranged from -$3.48M to $1.03B, with a median of $444.30M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $270.60M | -22.7% |
| 2025 | Dec 31, 2025 | $349.94M | -5.7% |
| 2024 | Dec 31, 2024 | $371.17M | -54.0% |
| 2023 | Dec 29, 2023 | $806.51M | – |
| 2022 | Dec 30, 2022 | -$3.48M | -100.6% |
| 2021 | Dec 31, 2021 | $632.84M | -46.9% |
| 2020 | Dec 31, 2020 | $1.19B | +838.4% |
| 2019 | Dec 31, 2019 | $127.07M | +14.0% |
| 2018 | Dec 31, 2018 | $111.46M | +52.1% |
| 2017 | Dec 29, 2017 | $73.27M | +79.7% |
| 2016 | Dec 30, 2016 | $40.78M | -83.3% |
| 2015 | Dec 31, 2015 | $244.80M | -26.1% |
| 2014 | Dec 31, 2014 | $331.47M | +145.0% |
| 2013 | Dec 31, 2013 | $135.27M | – |
| 2012 | Dec 31, 2012 | -$397.76K | – |
| 2011 | Dec 30, 2011 | -$1.61M | – |
See a number that looks wrong?